Skip to main content
. 2026 Jan 27;18(2):168. doi: 10.3390/pharmaceutics18020168
IPF Idiopathic pulmonary fibrosis
COPD Chronic obstructive pulmonary disease
AA Allergic asthma
M Million
ECM Extracellular matrix
EMT Epithelial–mesenchymal transition
ADI Alveolar differentiation intermediate
FN Fibronectin
LOX Lysyl oxidase
MUC Mucin
MMAD Mass median aerodynamic diameter
LAM Laminin
COL Collagen
TNC Tenascin C
VCAN Versican
FVC Forced vital capacity
BET Bromodomain and extra-terminal domain
BRD Bromodomain-containing protein
BD Bromodomain
CTGF Connective tissue growth factor
TGF-β Transforming growth factor-beta
LOXL Lysyl oxidase-like
PET Positron emission tomography
PEG Poly(ethylene glycol)
pSar Polysarcosine
siRNA Small interfering RNA
mRNA Messenger RNA
LNP Lipid nanoparticle
PAMAM Poly(amidoamine)
PLGA Poly(lactic-co-glycolic acid)
KRAS Kristen rat sarcoma viral oncogene
DPC Dendrimer–peptide conjugate
FF Fibroblastic foci
MMP Metalloproteinases